Elekta Ab Class B · OMXSTO:EKTA_B

Elekta Ab Class B — ASTRO 2017

45 slides from Elekta Ab Class B's conference presentation, Sep 26, 2017

  1. Slide 1: Welcome to ASTRO 2017

    and’science Of radiation oneology AS ne is A TRO AME CyElekta

  2. Slide 2: Important information

    Important information This presentation includes forward-looking statements including, but not limited to, statements relating to operational and financial performance, market conditions, and other similar matters. These forward-looking statements are based on current expectations about future event

  3. Slide 3: Richard Hausmann, PhD, President and CEO

    Richard Hausmann, PhD President and CEO Elekta AB

  4. Slide 4: The world today

    The world today 4 | Focus where it matters

  5. Slide 5: What is the difference between those two cars?

    What is the difference between those two cars? … and what does this have to do with radiotherapy? 5 | Focus where it matters

  6. Slide 6: It's the connectivity – the sensors – "system"

    It’s the connectivity – the sensors – and the intelligence built in the “system” 6 | Focus where it matters

  7. Slide 7: Global trends and the challenge to remain relevant

    Global trends and the challenge to remain relevant Info & analytics key to the future Interoperability needs are increasing Global connectivity for networks data sharing Expect a merging of [medical] disciplines … and more! 7 | Focus where it matters

  8. Slide 8: New technologies changing the future of medicine

    New technologies changing the future of medicine From paper maps [Films] to digital maps [PACS] to Google maps [Health Cloud] 8 | Focus where it matters

  9. Slide 9: Elekta today

    Elekta today 9 | Focus where it matters

  10. Slide 10: Professional services, software and treatment solutions

    PROFESSIONAL SOFTWARE SOLUTIONS Solutions to manage the oncology treatment SERVICES pathway and related data for the department/network, irrespective of choice of treatment & vendor New version TREATMENT SOLUTIONS SERVICE & SUPPORT Solutions to provide efficient and precise treatments (from Imaging,

  11. Slide 11: Product portfolio: MOSAIQ, Monaco, Versa HD, Unity, Gamma Knife

    PROFESSIONAL SOFTWARE MOSAIQ MOSAIQ METRIQ/LGK Oncology Oncology SERVICES SOLUTIONS Information System Analytics Cancer Registries Vendor agnostic Oncology Informatics AI enabled Pathway centric Monaco Image & Plan Plan of care Adaptive planning Review incl. PT Treatment pathway Management New versi

  12. Slide 12: Accelerating the technology transition

    We as Elekta are accelerating the technology transition: • OIS with MOA • SRS with HDdRS • Scan-plan-treat with our Unity* *Elekta Unity is not available for sale or distribution in the USA or Canada and has not been submitted for 510(k) premarket clearance

  13. Slide 13: FILM clip

    FILM clip 13 | Focus where it matters.

  14. Slide 14: Elekta Unity

    MR-linac Cone beam IGRT (future) (today) Esophagus Elekta Unity Bladder Brings together the capability of high-field diagnostic MR imaging, the highest standard of precision radiation therapy delivery and sophisticated adaptive workflow software for the first time. Rectal tumor

  15. Slide 15: Elekta Unity will revolutionize radiation therapy

    Elekta Unity* – will revolutionize radiation therapy • 16 systems as of today; 7 founding consortium sites and 9 additional hospitals • 5 in North America (R&D sites) • Interesting technology for many potential clients • Entrance to key university and teaching sites *Elekta Unity is not available fo

  16. Slide 16: Commercialization on track

    Commercialization on track ASTRO Target: 510k ESTRO September submission presentation 2017 2017 First patient Target: CE-mark RSNA treated 2017 2017 16 | Focus where it matters.

  17. Slide 17: First patient study completed at UMC

    First patient study completed at at UMC ”Analysis of the first clinically derived data shows that visibility of the treatment target and simultaneous radiation beam accuracy is excellent and beyond expectations”

  18. Slide 18: First-in-man treatments on Elekta Unity

    First-in-man treatments on Elekta Unity* Results “Better than expected” Images courtesy of Utrecht MC. Uncompromised diagnostic imaging quality Image anywhere, anytime High Speed (>15 images/s) High Resolution (<1mm3) Full breadth of diagnostic MR sequences Demonstrated technical accuracy and safety

  19. Slide 19: Long-term addressable market ~25% of installed linacs

    Long-term addressable market ~25% of current installed linacs TARGET Phase 1 Academic-driven phase 75 orders • High-profile clinics. until 2019 • ~300-400 units addressable market. 16 orders to date Momentum project - Further clinical research and data - Financial reimbursement/support Phase 2 Broad

  20. Slide 20: Elekta Unity – Innovation Platform

    Elekta Unity* – Innovation Platform *Elekta Unity is not available for sale or distribution in the USA or Canada and has not 20 | Focus where it matters been submitted for 510(k) premarket clearance

  21. Slide 21: Extraordinary potential with high field functional MR

    Extraordinary potential with high field functional MR First evidence, quantitative imaging on Elekta Unity* Online Functional/Biologic response T2 map = 2.5 min Potential for earlier treatment adaptation 4 types* of functional imaging proven robust ADC across Unity and 5 min conventional MR scanners

  22. Slide 22: Elekta's transformation

    Elekta’s transformation

  23. Slide 23: Our transformation since 2015/16 - achievements

    Our transformation since 2015/16 - achievements • Cost base reduction • Focus in R&D and innovation • Significant reduction of working capital and improved cash flow. Implementation of produce-to- installation process • Integration of past acquisitions • New organization, management and leadership d

  24. Slide 24: Visible results in improved cash flow and NWC

    Visible results in improved cash flow and NWC Net working capital Accrued income (SEK M) Improved cash conversion as % of sales (op cash flow / EBITDA) 12% 160% 150% 2 000 145% 8% 140% 126% 1 600 4% 120% 111% 1 200 0% 100% Q3 Q4 Q1 Q2 Q3 Q4 Q1 79% -4% 800 80% 60% -8% 400 60% -6% 11/12 12/13 13/14 14

  25. Slide 25: New management team

    New management team Richard Hausmann CEO Gustaf Salford CFO Ioannis Panagiotelis Chief Marketing and Sales Officer Maurits Wolleswinkel Head of Portfolio and Chief Strategy Officer Steven Wort Chief Operating Officer Elekta Conference, Brighton, May 2017 John Lapré Chief Technology Officer Peter Gac

  26. Slide 26: Foundation in place

    Foundation in place Values Organization Strategic priorities We work as one team We do what we say We keep thinking forward Company organized Updated brand in line with three key Growth processes Cost 26 | Focus where it matters.

  27. Slide 27: Our way forward has started

    Our way forward has started 2018/19 2016/17 2017/18 2018/19 • Year of change and building • Transformation delivers • Elekta Unity – growth driver the foundation for profitable full effect growth • Significant efficiency • Organization and improvements • Produce-to-order and ship- management in plac

  28. Slide 28: Targets for 2017/18

    Targets for 2017/18 Reach Net working capital Growth >20% EBITA <5% margin to net sales 28 | Focus where it matters.

  29. Slide 29: Welcome to ASTRO 2017!

    Welcome to ASTRO 2017! Ioannis Panagiotelis Chief Marketing and Sales Officer

  30. Slide 30: Highlights at ASTRO 2017

    Highlights at ASTRO 2017 - Largest booth space ever at ASTRO, 780m2 - Elekta Unity – central role (research system) - Unity pre-launch activities – evening event tonight 1,000 participants - Elekta Users meeting >600 participants - Complete portfolio showcased with common vision 30 | Focus where it

  31. Slide 31: Elekta User Meeting >600 participants

    Elekta User Meeting >600 participants China RAP 10% Key Note Speaker - Guy Kawasaki REU 3% 6% RLA 11% RNA 70% IT 5% Adminstrator Radiation 23% Therapist 19% Medical Dosimetrist Radiation 5% Oncologist 20% Medical Physicist 23% Other 3% Nurse 2%

  32. Slide 32: MR-linac reveal

    MR-linac reveal 32 | Focus where it matters

  33. Slide 33: Elekta evening event - TONIGHT

    Elekta evening event - TONIGHT Hilton San Diego Bayfront ~1 000 participants 33 | Focus where it matters.

  34. Slide 34: Our portfolio

    Our portfolio 34 | Focus where it matters

  35. Slide 35: 35 | Focus where it matters.

    35 | Focus where it matters.

  36. Slide 36: Leksell Gamma Knife Icon

    Leksell Gamma ® Knife ™ Icon

  37. Slide 37: 50 Leksell Gamma Knife Icon units in clinical use

    50 Leksell Gamma Knife Icon units in clinical use 25 16 9 Large cancer clinics adopting LGK Icon Cleveland Clinic, Cleveland, OH, Emory St. Joseph’s, Atlanta, GA, Univ Texas South West, Dallas, TX, MD Anderso 37 | Focus where it matters

  38. Slide 38: Versa HD

    Versa HD

  39. Slide 39: High definition dynamic radiosurgery

    MLC’s can be positioned in 1mm increments High definition dynamic Dynamic jaws radiosurgery can modulate within leaves to mimic 1mm Monaco + Agility + VMAT = resolution Fast delivery and low dose to surrounding healthy tissue

  40. Slide 40: MOSAIQ

    MOSAIQ ®

  41. Slide 41: MOSAIQ contains all the tools to support value based medicine

    MOSAIQ contains all the tools to support value based medicine today Workflow automation and Workflow quality control tools Electronic Film & patient customization Manually paper Oncology charts charting Analytics driven 2003 2005 2012 2015 2017 41 | Focus where it matters

  42. Slide 42: MOSAIQ Oncology Analytics

    MOSAIQ Oncology Analytics ." +@ e A. oe \ es

  43. Slide 43: Empower every action with MOA

    Empower every action with MOA Enhance Patient Care Optimize Operations Improve Cost Savings

  44. Slide 44: ASTRO 2017

    ASTRO 2017 EXTENSIVE MARKETING PROGRAM LEADING PRODUCT OFFERING INNOVATION LEADER WITH MR LINAC

  45. Slide 45: and/’science

    and/’science Of radiation oneology CyElekta

Elekta — ASTRO 2017 on 6ix